SCHEMBL3319892

SCHEMBL3319892

CCC(C(=O)O)n1nnc(-c2cc(O)no2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.51
ALDH1A1 P00352 2/20 0.51
HPGD P15428 1/20 0.51
MAPK1 P28482 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
HSD17B10 Q99714 1/20 0.51
SCD O00767 3/20 0.32
GRIK1 P39086 2/20 0.32
GRIA1 P42261 2/20 0.32
GRIA2 P42262 2/20 0.32
GRIA3 P42263 2/20 0.32
GRIA4 P48058 2/20 0.32
SCD5 Q86SK9 2/20 0.31
PPARG P37231 2/20 0.31
PPARA Q07869 2/20 0.31
NPSR1 Q6W5P4 1/20 0.31
HCAR3 P49019 1/20 0.30
TP53 P04637 1/20 0.30
MAPT P10636 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3324193 0.78 MAPK1 (0.46) KDM4EALDH1A1HPGDMAPK1SMN1; SMN2
SCHEMBL3350358 0.77 KDM4E (0.44) KDM4EALDH1A1HPGDMAPK1SMN1; SMN2
SCHEMBL3324070 0.77 KDM4E (0.44) KDM4EALDH1A1HPGDMAPK1SMN1; SMN2
SCHEMBL3350351 0.77 KDM4E (0.44) KDM4EALDH1A1HPGDMAPK1SMN1; SMN2
SCHEMBL3323897 0.74 SMN1; SMN2 (0.60) KDM4EALDH1A1HPGDMAPK1SMN1; SMN2
SCHEMBL3100029 0.74 SCD (0.53) ALDH1A1HPGDSCDSCD5
SCHEMBL1238494 0.71 KDM4E (0.51) KDM4EALDH1A1HPGDMAPK1SMN1; SMN2
SCHEMBL3227629 0.71 ALDH1A1 (0.54) ALDH1A1MAPK1HSD17B10SCDSCD5
SCHEMBL3324160 0.71 SCD (0.67) KDM4EALDH1A1HPGDMAPK1SMN1; SMN2
SCHEMBL14629954 0.70 ALDH1A1 (0.70) KDM4EALDH1A1HPGDMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100120784-A1 NOVEL HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120784-A1 NOVEL HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE SCD, SCD5, ACSL6 KDM4E 2490/4885ALDH1A1 2012/4885HPGD 1610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.